Sunday, 31 January 2010
Otolaryngology Event Calender 2010
Click here to View updated Event Calender
Feedback/Query/contribute
update@entindia.net
We thrive on your support
Join the Rhinoplasty Forum -Dr Lionel Azan ( Paris )
Saturday, 30 January 2010
22nd Microsurgery of the ear workshop,12th and 13th feb.2011 at Sir Ganga ram Hospital
We are glad to announce 22nd microsurgery of the ear workshop, which will be held on 12th and 13th feb.2011 at Sir Ganga ram Hospital.There will be live interactive sessions on middle ear and mastoid surgeries, ossiculoplasties using prosthesis,BAHA surgery and facial nerve decompression and grafting. Demonstration of temporal bone dissection and session of discussion on different aspects of middle ear and mastoind surgeries will also be held.
Contact Dr Shalabh
9810121977
Contact Dr Shalabh
9810121977
Thyroid lab tests explained in under 150 words
The two (TSH and T4) are opposite of each other – high T4/low TSH or low T4/high TSH – that means that the problem is intrinsic to the thyroid gland (Graves disease or Hashimoto thyroiditis, for example) and the pituitary is trying to control the thyroid by producing more or less TSH. Those are the most common types of thyroid disease – those that are intrinsic, or primary to the thyroid gland itself.
On the other hand, if both TSH and T4 are either low or high – high T4/high TSH or low T4/low TSH – that means that the process is being driven by TSH. Either there’s a pituitary adenoma making a ton of TSH, or the pituitary is not working well for whatever reason (it’s been radiated, or has undergone necrosis) and it’s not making enough TSH.
On the other hand, if both TSH and T4 are either low or high – high T4/high TSH or low T4/low TSH – that means that the process is being driven by TSH. Either there’s a pituitary adenoma making a ton of TSH, or the pituitary is not working well for whatever reason (it’s been radiated, or has undergone necrosis) and it’s not making enough TSH.
Antro-choanal Polyp Revisited :
With presence of this massive mass in nose and nasopharynx .
But CT Scan shows a clear ipsilateral Maxillary Antrum !
Dr kapil sikka said...
Its a nasochoanal polyp!!
Read more...
Dual disease -CLL +SCC
Chronic lymphocytic leukaemia in the right half of the field, and fibrous tissue containing squamous cell carcinoma in the left (haematoxylin and eosin, original magnification ×200).
Authors describe a case in which ultrasound-guided fine needle core biopsy of a cervical lymph node enabled diagnosis of dual disease. Histological examination of the core biopsy confirmed unsuspected chronic lymphocytic leukaemia with an isolated focus of metastatic squamous cell carcinoma (SCC), and enabled optimal preoperative planning of treatment. Such a case is extremely unusual and provides evidence of the accurate diagnosis that can be obtained from nodal investigations using ultrasound-guided core biopsy.
Link
Authors describe a case in which ultrasound-guided fine needle core biopsy of a cervical lymph node enabled diagnosis of dual disease. Histological examination of the core biopsy confirmed unsuspected chronic lymphocytic leukaemia with an isolated focus of metastatic squamous cell carcinoma (SCC), and enabled optimal preoperative planning of treatment. Such a case is extremely unusual and provides evidence of the accurate diagnosis that can be obtained from nodal investigations using ultrasound-guided core biopsy.
Link
Merkel cell carcinoma (MCC)
Merkel cell carcinoma (MCC) is an uncommon and aggressive cutaneous neoplasm that lacks distinguishing clinical features. More than half of Merkel cell carcinomas (MCCs) occur in the head and neck of elderly people in areas of actinically damaged skin. The most common site of occurrence is the periorbital region. Merkel cell carcinoma (MCC) has a propensity to recur and to cause local and distant metastases. Distant metastases indicate a condition that is nearly always fatal.
The diagnosis is based on a combination of light microscopy, electron microscopy, and immunohistochemistry. Current treatment consists of wide local excision with adjuvant irradiation. Neck dissection is used for clinically positive nodes, and chemotherapy is given for advanced disease.
http://www.merkelcell.org/
The diagnosis is based on a combination of light microscopy, electron microscopy, and immunohistochemistry. Current treatment consists of wide local excision with adjuvant irradiation. Neck dissection is used for clinically positive nodes, and chemotherapy is given for advanced disease.
http://www.merkelcell.org/
Thursday, 28 January 2010
2nd International Course on Sialendoscopy,November 12-13,2010
Venue: UCMS & GTB Hospital, Delhi
Dates : November 12-13, 2010
Course Director: Dr P P Singh
Prof & Head, Deptt of ENT
UCMS & GTB Hospital, Delhi
Guest Faculty: Dr Francis Marchal, Director
European Sialendoscopy Training Center
Geneva
Org Secretary: Dr Arun Goyal
drarungoyal150@yahoo.co.in
M:9810812813
Website: www.otologyindia.blogspot.com
Early discounted registration may be availed at Rs 1000/- (non-refundable) before Feb 15, 2010. DD in favour of "Otology Workshop - GTBH" payable at New Delhi may be sent to:
Dr Arun Goyal,
Reader, Deptt of ENT
Room No 352, OPD Block
UCMS & GTB Hospital, Dilshad Garden
Delhi - 110 095
Thanking you
Dr P P Singh
Dates : November 12-13, 2010
Course Director: Dr P P Singh
Prof & Head, Deptt of ENT
UCMS & GTB Hospital, Delhi
Guest Faculty: Dr Francis Marchal, Director
European Sialendoscopy Training Center
Geneva
Org Secretary: Dr Arun Goyal
drarungoyal150@yahoo.co.in
M:9810812813
Website: www.otologyindia.blogspot.com
Early discounted registration may be availed at Rs 1000/- (non-refundable) before Feb 15, 2010. DD in favour of "Otology Workshop - GTBH" payable at New Delhi may be sent to:
Dr Arun Goyal,
Reader, Deptt of ENT
Room No 352, OPD Block
UCMS & GTB Hospital, Dilshad Garden
Delhi - 110 095
Thanking you
Dr P P Singh
Dr. Wolfgang Steiner at International Workshop on Laser surgery at Medanta Medicity , Gurgaon
Dr Naresh Trehan introducing Dr Steiner (Middle).Dr KK Handa(Right)
Born in Crailsheim, Germany in 1942, Dr. Steiner was a member of the German Air Force from 1961 to 1963. After receiving his medical degree and finishing his training at in internal medicine and general surgery at the University of Erlangen/Nürnberg Medical School in Germany, he remained on staff there in the Department of Otolaryngology for fifteen years. Dr. Steiner was appointed as Professor and Chair of Otolaryngology at the University of Göttingen in 1986 and still holds this position today.
Dr. Steiner has been involved in research concerning endoscopic, microscopic and laser neck surgery since the late 1970s. He is internationally renowned for his development of minimally invasive surgical techniques for cancers of the larynx, transforming what was once a radical notion - the resection of head and neck cancers without damaging open surgery - into a reality for thousands of his patients.
Wednesday, 27 January 2010
ENTUK Position Papers 2009 Tonsillectomy
Tonsillectomy, the removal of the palatine tonsils, has three principal
indications.
1. Recurrent attacks of tonsillitis (typically Streptococcal).
2. Enlarged tonsils causing obstruction of the airway, which may be the
cause of Obstructive Sleep Apnoea – recurrent airway obstruction at
night – and this has serious effects on health and wellbeing.
3. Possible malignant disease in the tonsils – typically squamous carcinoma
or lymphoma.
For many years the UK guidance on tonsillectomy for tonsillitis has been only to
consider surgery in those with attacks of at least moderate severity (several
days’ duration) per annum, for > 1 year – the SIGN guidance summarises the
current consensus 1:
Patients should meet all of the following criteria:
•sore throats are due to tonsillitis
•five or more episodes of sore throat per year
•symptoms for at least a year
•episodes of sore throat are disabling and prevent normal functioning
Those with very frequent infection (>8 per annum) or who are hospitalised with
extremely severe tonsillitis or peritonsillar abscess (quinsy) may seek
intervention within a year of symptom onset. Very similar guidance has evolved
independently in the USA and Australia.
click here to read more
indications.
1. Recurrent attacks of tonsillitis (typically Streptococcal).
2. Enlarged tonsils causing obstruction of the airway, which may be the
cause of Obstructive Sleep Apnoea – recurrent airway obstruction at
night – and this has serious effects on health and wellbeing.
3. Possible malignant disease in the tonsils – typically squamous carcinoma
or lymphoma.
For many years the UK guidance on tonsillectomy for tonsillitis has been only to
consider surgery in those with attacks of at least moderate severity (several
days’ duration) per annum, for > 1 year – the SIGN guidance summarises the
current consensus 1:
Patients should meet all of the following criteria:
•sore throats are due to tonsillitis
•five or more episodes of sore throat per year
•symptoms for at least a year
•episodes of sore throat are disabling and prevent normal functioning
Those with very frequent infection (>8 per annum) or who are hospitalised with
extremely severe tonsillitis or peritonsillar abscess (quinsy) may seek
intervention within a year of symptom onset. Very similar guidance has evolved
independently in the USA and Australia.
click here to read more
Role of surgery in treating glue ear
The only effective intervention for treating childhood hearing loss caused by glue
ear (otitis media with effusion; OME) is the insertion of grommets, (ventilation
tubes). In selected cases removal of the adenoid from the back of the nose,
adjacent to the Eustachian tube opening (which allows air pressure equilibration)
is also recommended. Grommet insertion and adenoidectomy work by reducing
low grade infective biofilm 1 load in the back of the nose, and causing a massive
increase in oxygen tension in the middle ear; this in turn, further inhibits
inflammation mucin gene activity and hence the formation of middle ear fluid
(glue)2. Most grommet and adenoid procedures are carried out as day cases with
very little systemic morbidity or risk.
OME (Glue Ear)/ Adenoid and Grommet Position Paper ENT UK 2009 -- click here to read
ear (otitis media with effusion; OME) is the insertion of grommets, (ventilation
tubes). In selected cases removal of the adenoid from the back of the nose,
adjacent to the Eustachian tube opening (which allows air pressure equilibration)
is also recommended. Grommet insertion and adenoidectomy work by reducing
low grade infective biofilm 1 load in the back of the nose, and causing a massive
increase in oxygen tension in the middle ear; this in turn, further inhibits
inflammation mucin gene activity and hence the formation of middle ear fluid
(glue)2. Most grommet and adenoid procedures are carried out as day cases with
very little systemic morbidity or risk.
OME (Glue Ear)/ Adenoid and Grommet Position Paper ENT UK 2009 -- click here to read
Workshop on Otology and Skull-base Surgery on 28th and 29th August 2010 in Government ENT Hospital, Viskhapatnam.
We are organising a Workshop on Otology and Skull-base Surgery on 28th and 29th August 2010 in Government ENT Hospital, Viskhapatnam.
Dr.Manyan (France) and Dr PP Singh( Delhi) will be the Guest Faculty
We are expecting about 300 delegates from Andhra Pradesh and neighbouring states.
Visakhapatnam is the 2nd biggest city in Andhra Pradesh, its know as the ' City Of Destiny ' and it has a beautiful coastal line.I would like to inform you that there are direct flights from Delhi to Visakhapatnam .
Sir we are looking forward for your acceptance.
Thanking you.
Yours Sincerely,
Dr.S.Surya Prakasa Rao
Associate Professor of ENT, Andhra Medical College,Visakhapatnam, Andhra Pradesh
Former Secretary of AP State AOI and presently Chief Co-ordinator of North Coastal Andhra Association of AOI.
Contact : sreerama.priyanka@gmail.com
Dr.Manyan (France) and Dr PP Singh( Delhi) will be the Guest Faculty
We are expecting about 300 delegates from Andhra Pradesh and neighbouring states.
Visakhapatnam is the 2nd biggest city in Andhra Pradesh, its know as the ' City Of Destiny ' and it has a beautiful coastal line.I would like to inform you that there are direct flights from Delhi to Visakhapatnam .
Sir we are looking forward for your acceptance.
Thanking you.
Yours Sincerely,
Dr.S.Surya Prakasa Rao
Associate Professor of ENT, Andhra Medical College,Visakhapatnam, Andhra Pradesh
Former Secretary of AP State AOI and presently Chief Co-ordinator of North Coastal Andhra Association of AOI.
Contact : sreerama.priyanka@gmail.com
Lingual thyroid
Lingual thyroid is a rare condition, with an incidence of 1:100,000. This infrequent congenital anomaly is often asymptomatic until a pathologic stress such as systemic disease or physiologic stress such as puberty causes enlargement of the ectopic tissue, leading to dysphagia, dysphonia, and dyspnea.
The work-up should include routine blood work including thyroid function tests thyrotropin, thyroxine, and thyroid hormone binding ratio; iodine thyroid scintigraphy; and computerized tomography or magnetic resonance imaging. The majority of patients require surgical excision of the symptomatic mass and, in case of absence of orthotopic thyroid tissue, long-term thyroid hormone replacement.
Read More ...
View Pics
A case for operated by Dr Steiner at Medanta Hospital,Gurgaon, today by CO 2 Laser
The work-up should include routine blood work including thyroid function tests thyrotropin, thyroxine, and thyroid hormone binding ratio; iodine thyroid scintigraphy; and computerized tomography or magnetic resonance imaging. The majority of patients require surgical excision of the symptomatic mass and, in case of absence of orthotopic thyroid tissue, long-term thyroid hormone replacement.
Read More ...
View Pics
A case for operated by Dr Steiner at Medanta Hospital,Gurgaon, today by CO 2 Laser
T Temporal Bone Dissection and Live Ear Surgery Course, Pushpanjali Crosslay Hospital, Feb 14-15, 2010
click image to enlarge
click here to download
Invitation
Pushpanjali Crosslay Hospital in collaboration with Claros Foundation, Barcelona,
Spain is organizing the 3rd International Temporal Bone Dissection and Live Ear
Surgery Course on 14 and 15 February, 2010.
We invite you to register for this course, which will be conducted by renowned
international faculty.
Sincerely,
Dr Atul Jain
Course Director
Mobile: 9811120545
Tuesday, 26 January 2010
Distinguished Humanitarian Award AAO
American Academy of Otolaryngology—Head and Neck Surgery Final Call for Nominations - 2010 Distinguished Humanitarian Award February 1 is the deadline to nominate a colleague for the 2010 Distinguished Humanitarian Award.
For information, contact humanitarian@entnet.org.
For information, contact humanitarian@entnet.org.
Discussion : Is MCI unfair to Doctors ?
I want to place my views as a Doctor on
MCI's latest Guideline which I hope every reader will surely read and
evaluate critically.
Unfair MCI(MEDICAL COUNCIL OF INDIA): Being a Doctor practicing
Medicine since last 24 years I can clearly see that latest MCI
guideline issued for 'so called"ethical practice are unreasonable.Thet are probably in collusion with MNC pharma companies. Let me explain you why I say so.
++At the outset I must agree that I am not in favor of Heavy and costly
Gifts being Given by Pharma Companies just to get prescriptions for
their products, this is surely a wrong practice and is prevalent very
much. I don’t subscribe to this practice.This should stop.
On the other hand let us try to understand the facts as on today and
what is happening in the real world which is totally dictated by
simple COMMERCE ! and No One Objects to these !
1.Doctors are now being labeled as ‘Health Care Providers’ ( no more
next to God status etc)who, for monetary considerations they are
practicing a ‘Profession’ and that profession and all it’s services
are to be covered under ‘Consumer Protection Act( CPA)’ and Health
Care Seeker is a Consumer.So it is a Commercial Activity like any
other “Service”
2.Insurance companies ,if the patient is covered under a policy, do
have a say in Billings, Rates of Services/Operations, Choice Of
Hospital and Hospital Stay, even Selection Of Hospital for a particular
procedure etc and all this is designed to get maximum from Hospitals
in Best of the patient’s interest with minimum of cost or money spent
by them .and patients do obey their dictats as policy holders.No
questions asked!
3.The practice of having Doctors and Hospitals on panel by different
organizations/MNCs etc is also an effort in the same direction of
getting rebates/.cuts/discounted rates. Money matters prevail.
4.Corpoarte Hospitals in the "Health Care field which is considered
as Health Care Industry and as a Services Industry" and they openly
offer Packages, Incentives, Discounts .They(Hospitals) themselves also
ask for Discounts, Packages, Special Rates while purchasing Medicines,
Appliances, Disposables etc from Pharma and other companies For
example if more then One Stent is to be placed in your Coronary
Artery, the “offer” goes like : First Stent 70,000 Rs and Second for
say 40,000 Rs !
5. Many of the Doctors/Services are Outsourced or Hired on Day To Day
or Hourly basis.
6.Hospitals ,Corporate or others, on one side and Pharma and Equipment
supplying Industry on the other side are totally, openly and blatantly
are all working for one single aim MORE AND MORE PROFITS !. To attract
patients what all is being done around us is clearly visible to all in
print and electronic media.
7.What I mean to say is that it is now a “Big Commercial World of
Health Care” guided by simple commerce and all the relevant “market
forces” ,where each one involved wants to earn .
8. ALL THIS JUST CAN NOT RUN WITHOUT DOCTORS ! THEY ARE THE KEY PEOPLE WITHOUT THEM EACH AND EVERYTHING ELSE IS JUST OF NO USE !
These (Poor! )Doctors have to prescribe Medicines and that is their
job! You can’t cure disease without prescriptions. Choosing a right
drug for a right patient is a doctor’s job. But They ARE NOT SUPPOSED
TO ASK EVEN FOR ANY SHARE IN PROFITS ,THEY ARE NOBLEST OF HUMAN
BEINGS! NOW THEY ARE SUPPOSED TO BE NEXT TO GODS! UNDER OATH AND
BOUND BY ETHICS! WHEN IT COMES TO SHARING PAYMENTS /PROFITS THEY ARE NOT COMMERCE EARNING SERVICE PROVIDERS,CANT ASK FOR BENEFITS, THEY SHOULD KEEP QUIET!
BUT also No Doctor on the Earth will write a Medicine, if it is not
needed in a particular situation. Government has allowed many pharma
companies to produce same drug under different brand names and many of
the Brands are “Brands” just because the share of prescriptions it has
got from Doctors ,which of-course comes because of the years of faith
either in the Company or in The Drug. Many Brand have made Big names
for the Companies!
Choice of that Brand is based upon many factors and that surely
Includes the activities of that company which are designed to improve
that particular Doctors’ Practice.
For years and ages Companies do spend a part of their Profits on the
activities like sponsoring the Doctor For a Conference, a membership
of an organization, tickets for travel to Conference, stay at Hotel
and for things improving Clinic’s performance and efficiency, like
giving Computer Software etc . These are done no doubt to get even
bigger profits ,but in the process the Doctor gets updated in
knowledge and skills, patients are benefitted for sure.
Needless to say that an Indian Doctor, charging 3-4 Dollars as Fees
from his patient can never afford a Conference say in Chicago ,costing
5000 US Dollars!
Banning such activities and Gifts which can improve Doctors' and
Clinic performance is a great injustice to the Medical Fraternity and
to Individual poor Doctor ,BECAUSE OF WHOM EVERYONE ELSE IS EARNING
CRORES !. In fact MCI is playing in the hands of Corporates and
Pharma. They will happily share the booty of “ savings” amongst
themselves.
9.Amother interesting part keeps happening in all Hospitals: An example: An antibiotic Brand A costs-printed Rs 750/- ,per Injection but Hospital gets it at Rs. 350/- and purchases 1000 Injections, company happily Gifts 2 LCD TVs to the Hospital Reception. This lot can ONLY be consumed if Doctor prescribes Brand A But if Doctor prefers Brand B ,because it has Print Price Rs 550/- and patient gets savings of Rs 200/- ,then Hospital Pharmacy will still push Brand A because Hospital stocks that brand, because Hospital got Gifts of LCD TVs--THIS IS NOT A HYPOTHETICAL SITUATION THis actually is happening in Corporate Hospitals.BUT Doctor who prescribes and Consumes the stock through his prescriptions is NOT supposed to take any Gift from that Pharma Company !
10. If banned, Sponsorships will no doubt then come through dubious sources
involving more corruption or may be even Hawala Transactions! Because
these things are surely are not going to stop !
11.Such activities(Conference Sponsorhips) are fully justified because Doctors Do Deserve some
share in Ethical activities in Ethical ways since Healthcare is now a
Service Providing Industry Guided by all relevant market forces !Pharma Market is not being run by any company for charity! Let
the Doctors decide the fine line of Ethical and unethical ,themselves!
GOT THIS AS FORWARDED MAIL: YET TO TRACE AUTHOR
SEND THIS MAIL TO AS MANY DOCTORS AS YOU CAN
Comments Welcome
MCI's latest Guideline which I hope every reader will surely read and
evaluate critically.
Unfair MCI(MEDICAL COUNCIL OF INDIA): Being a Doctor practicing
Medicine since last 24 years I can clearly see that latest MCI
guideline issued for 'so called"ethical practice are unreasonable.Thet are probably in collusion with MNC pharma companies. Let me explain you why I say so.
++At the outset I must agree that I am not in favor of Heavy and costly
Gifts being Given by Pharma Companies just to get prescriptions for
their products, this is surely a wrong practice and is prevalent very
much. I don’t subscribe to this practice.This should stop.
On the other hand let us try to understand the facts as on today and
what is happening in the real world which is totally dictated by
simple COMMERCE ! and No One Objects to these !
1.Doctors are now being labeled as ‘Health Care Providers’ ( no more
next to God status etc)who, for monetary considerations they are
practicing a ‘Profession’ and that profession and all it’s services
are to be covered under ‘Consumer Protection Act( CPA)’ and Health
Care Seeker is a Consumer.So it is a Commercial Activity like any
other “Service”
2.Insurance companies ,if the patient is covered under a policy, do
have a say in Billings, Rates of Services/Operations, Choice Of
Hospital and Hospital Stay, even Selection Of Hospital for a particular
procedure etc and all this is designed to get maximum from Hospitals
in Best of the patient’s interest with minimum of cost or money spent
by them .and patients do obey their dictats as policy holders.No
questions asked!
3.The practice of having Doctors and Hospitals on panel by different
organizations/MNCs etc is also an effort in the same direction of
getting rebates/.cuts/discounted rates. Money matters prevail.
4.Corpoarte Hospitals in the "Health Care field which is considered
as Health Care Industry and as a Services Industry" and they openly
offer Packages, Incentives, Discounts .They(Hospitals) themselves also
ask for Discounts, Packages, Special Rates while purchasing Medicines,
Appliances, Disposables etc from Pharma and other companies For
example if more then One Stent is to be placed in your Coronary
Artery, the “offer” goes like : First Stent 70,000 Rs and Second for
say 40,000 Rs !
5. Many of the Doctors/Services are Outsourced or Hired on Day To Day
or Hourly basis.
6.Hospitals ,Corporate or others, on one side and Pharma and Equipment
supplying Industry on the other side are totally, openly and blatantly
are all working for one single aim MORE AND MORE PROFITS !. To attract
patients what all is being done around us is clearly visible to all in
print and electronic media.
7.What I mean to say is that it is now a “Big Commercial World of
Health Care” guided by simple commerce and all the relevant “market
forces” ,where each one involved wants to earn .
8. ALL THIS JUST CAN NOT RUN WITHOUT DOCTORS ! THEY ARE THE KEY PEOPLE WITHOUT THEM EACH AND EVERYTHING ELSE IS JUST OF NO USE !
These (Poor! )Doctors have to prescribe Medicines and that is their
job! You can’t cure disease without prescriptions. Choosing a right
drug for a right patient is a doctor’s job. But They ARE NOT SUPPOSED
TO ASK EVEN FOR ANY SHARE IN PROFITS ,THEY ARE NOBLEST OF HUMAN
BEINGS! NOW THEY ARE SUPPOSED TO BE NEXT TO GODS! UNDER OATH AND
BOUND BY ETHICS! WHEN IT COMES TO SHARING PAYMENTS /PROFITS THEY ARE NOT COMMERCE EARNING SERVICE PROVIDERS,CANT ASK FOR BENEFITS, THEY SHOULD KEEP QUIET!
BUT also No Doctor on the Earth will write a Medicine, if it is not
needed in a particular situation. Government has allowed many pharma
companies to produce same drug under different brand names and many of
the Brands are “Brands” just because the share of prescriptions it has
got from Doctors ,which of-course comes because of the years of faith
either in the Company or in The Drug. Many Brand have made Big names
for the Companies!
Choice of that Brand is based upon many factors and that surely
Includes the activities of that company which are designed to improve
that particular Doctors’ Practice.
For years and ages Companies do spend a part of their Profits on the
activities like sponsoring the Doctor For a Conference, a membership
of an organization, tickets for travel to Conference, stay at Hotel
and for things improving Clinic’s performance and efficiency, like
giving Computer Software etc . These are done no doubt to get even
bigger profits ,but in the process the Doctor gets updated in
knowledge and skills, patients are benefitted for sure.
Needless to say that an Indian Doctor, charging 3-4 Dollars as Fees
from his patient can never afford a Conference say in Chicago ,costing
5000 US Dollars!
Banning such activities and Gifts which can improve Doctors' and
Clinic performance is a great injustice to the Medical Fraternity and
to Individual poor Doctor ,BECAUSE OF WHOM EVERYONE ELSE IS EARNING
CRORES !. In fact MCI is playing in the hands of Corporates and
Pharma. They will happily share the booty of “ savings” amongst
themselves.
9.Amother interesting part keeps happening in all Hospitals: An example: An antibiotic Brand A costs-printed Rs 750/- ,per Injection but Hospital gets it at Rs. 350/- and purchases 1000 Injections, company happily Gifts 2 LCD TVs to the Hospital Reception. This lot can ONLY be consumed if Doctor prescribes Brand A But if Doctor prefers Brand B ,because it has Print Price Rs 550/- and patient gets savings of Rs 200/- ,then Hospital Pharmacy will still push Brand A because Hospital stocks that brand, because Hospital got Gifts of LCD TVs--THIS IS NOT A HYPOTHETICAL SITUATION THis actually is happening in Corporate Hospitals.BUT Doctor who prescribes and Consumes the stock through his prescriptions is NOT supposed to take any Gift from that Pharma Company !
10. If banned, Sponsorships will no doubt then come through dubious sources
involving more corruption or may be even Hawala Transactions! Because
these things are surely are not going to stop !
11.Such activities(Conference Sponsorhips) are fully justified because Doctors Do Deserve some
share in Ethical activities in Ethical ways since Healthcare is now a
Service Providing Industry Guided by all relevant market forces !Pharma Market is not being run by any company for charity! Let
the Doctors decide the fine line of Ethical and unethical ,themselves!
GOT THIS AS FORWARDED MAIL: YET TO TRACE AUTHOR
SEND THIS MAIL TO AS MANY DOCTORS AS YOU CAN
Comments Welcome
Endoscopic sinus surgery workshop from 29th to 31st Jan 2010
Dear All,
Please find attached the ebrochure for the 15th endoscopic sinus surgery workshop from 29th to 31st Jan 2010 to held at Kohinoor Hall, Hotel Taj Deccan, Hyderabad. Please inform your collegues & do attend.
Regards
Dr. KR Meghanadh
Organizing Secretary
+91 98490-44775
Maa ENT Institute
Hyderabad
www.maaentinstitute.com
Click here to view brochure
Please find attached the ebrochure for the 15th endoscopic sinus surgery workshop from 29th to 31st Jan 2010 to held at Kohinoor Hall, Hotel Taj Deccan, Hyderabad. Please inform your collegues & do attend.
Regards
Dr. KR Meghanadh
Organizing Secretary
+91 98490-44775
Maa ENT Institute
Hyderabad
www.maaentinstitute.com
Click here to view brochure
Monday, 25 January 2010
Pleomorphic Adenoma of Submandibular Gland
Discussion Forum : ethnical rhinoplasty
Saturday, 23 January 2010
Spontaneous regression of cancer: possible mechanisms
In Vivo. 1998 Nov-Dec;12(6):571-8.
Spontaneous regression of cancer: possible mechanisms.
Papac RJ.
Section of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.
Spontaneous regression of cancer is reported in virtually all types of human cancer, although the greatest number of cases are reported in patients with neuroblastoma, renal cell carcinoma, malignant melanoma and lymhomas/leukemias. Study of patients with these diseases has provided most of the data regarding mechanisms of spontaneous regression.
Mechanisms proposed for spontaneous regression of human cancer include: immune mediation, tumor inhibition by growth factors and/or cytokines, induction of differentiation, hormonal mediation, elimination of a carcinogen, tumor necrosis and/or angiogenesis inhibition, psychologic factors, apoptosis and epigenetic mechanisms.
Clinical observations and laboratory studies support these concepts to a variable extent. The induction of spontaneous regression may involve multiple mechanisms in some cases although the end result is likely to be either differentiation or cell death. Elucidation of the process of spontaneous regression offers the possibility of improved methods of treating and preventing cancer.
PMID: 9891219 [PubMed - indexed for MEDLINE]
Spontaneous regression of cancer: possible mechanisms.
Papac RJ.
Section of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.
Spontaneous regression of cancer is reported in virtually all types of human cancer, although the greatest number of cases are reported in patients with neuroblastoma, renal cell carcinoma, malignant melanoma and lymhomas/leukemias. Study of patients with these diseases has provided most of the data regarding mechanisms of spontaneous regression.
Mechanisms proposed for spontaneous regression of human cancer include: immune mediation, tumor inhibition by growth factors and/or cytokines, induction of differentiation, hormonal mediation, elimination of a carcinogen, tumor necrosis and/or angiogenesis inhibition, psychologic factors, apoptosis and epigenetic mechanisms.
Clinical observations and laboratory studies support these concepts to a variable extent. The induction of spontaneous regression may involve multiple mechanisms in some cases although the end result is likely to be either differentiation or cell death. Elucidation of the process of spontaneous regression offers the possibility of improved methods of treating and preventing cancer.
PMID: 9891219 [PubMed - indexed for MEDLINE]
Friday, 22 January 2010
The Egyptian International Otolaryngology Congress 2010,March 3-6,2010
The Egyptian International
Otolaryngology Congress 2010
Organized by
The Ear, Nose and Throat
Department at Ain Shams University
The Egyptian Society of Ear, Nose,
Throat and Allied Sciences
March 3-6, 2010
Sharm El-Sheikh – Egypt
www.orlainshams2010.com
Dr PP Singh (Delhi)invited as International Faculty
Otolaryngology Congress 2010
Organized by
The Ear, Nose and Throat
Department at Ain Shams University
The Egyptian Society of Ear, Nose,
Throat and Allied Sciences
March 3-6, 2010
Sharm El-Sheikh – Egypt
www.orlainshams2010.com
Dr PP Singh (Delhi)invited as International Faculty
Different types of stroma in pleomorphic adenoma
Click image to Enlarge
Image A shows a myxoid stroma. Note the dispersed spindle myoepithelial cells in the stroma, some of which have a stellate morphology. Image B shows a chondroid stroma. Image C shows stroma with cartilage formation. Image D shows a hyalinized stroma.
Read more..
Oto-toxic Drugs: List from House Ear Institute
Cinchona alkaloids
Minimum risk, usually temporary and reversible
Quinidine
Chloroquine
Quinine (Q-vel®)
Salycilates
Compounds containing Aspirin may cause hearing problems in high doses (20-30 tablets per day) though this is reversible.)
Acetaminophen
Aspirin
Anti-inflammatory Agents
Problems seen in patients with sensitivity, symptoms reversible
Pyrazolones
Ibuprofen (propionic acids)
Ascetic acids
Aminoglycosides
Listed in order of toxicity, these drugs are given only by IV/injection, not orally. They can affect either hearing, balance or both.
Neomycin
Streptomycin
Kanamycin
Amikacin, Gentamicin
Tobramycin
Netilmicin
Rinostamycin
Dihydrostreptomycin
Read More..
Minimum risk, usually temporary and reversible
Quinidine
Chloroquine
Quinine (Q-vel®)
Salycilates
Compounds containing Aspirin may cause hearing problems in high doses (20-30 tablets per day) though this is reversible.)
Acetaminophen
Aspirin
Anti-inflammatory Agents
Problems seen in patients with sensitivity, symptoms reversible
Pyrazolones
Ibuprofen (propionic acids)
Ascetic acids
Aminoglycosides
Listed in order of toxicity, these drugs are given only by IV/injection, not orally. They can affect either hearing, balance or both.
Neomycin
Streptomycin
Kanamycin
Amikacin, Gentamicin
Tobramycin
Netilmicin
Rinostamycin
Dihydrostreptomycin
Read More..
Tuesday, 19 January 2010
Monday, 18 January 2010
Search this Blog
The blog search made easy
Now you can extract information of your choice by putting the key word in the blog search space.
This feature takes time to load at times.
Suggested key words : 2009,2010.rhinoplasty,FESS,Temporal Bone ,Laser etc
We thrive on your feedback
update@entindia.net
Now you can extract information of your choice by putting the key word in the blog search space.
This feature takes time to load at times.
Suggested key words : 2009,2010.rhinoplasty,FESS,Temporal Bone ,Laser etc
We thrive on your feedback
update@entindia.net
11th Course on NEUROTOLOGY & MEDICAL AUDIOLOGY
11th Course on NEUROTOLOGY & MEDICAL AUDIOLOGY
26-28 February 2010
VENUE
SAHARA STAR HOTEL
MUMBAI AIRPORT
conducted by Dr Anirban Biswas
consultant neurotologistKolkata
website www.dranirbanbiswas.com
Fax 0091-33-23215763
Contact
Rahul Sharma
09831477573
09836725371
26-28 February 2010
VENUE
SAHARA STAR HOTEL
MUMBAI AIRPORT
conducted by Dr Anirban Biswas
consultant neurotologistKolkata
website www.dranirbanbiswas.com
Fax 0091-33-23215763
Contact
Rahul Sharma
09831477573
09836725371
Saturday, 16 January 2010
Friday, 15 January 2010
AOI Archives:1989
Prof.U.Prasad ,HOD,University of Malaya and a member of AOI received "TUN ABDUL RAZAK INTERNATIONAL AWARD for 1989.It is similar to Magasaysay Award and is given once in two years.He has been given this award in recognition of his international standing in field of research on Nasopharyngeal Carcinoma
Dr S.Kameswaran (Madras)delivered Guest Lecture on Otolarynglogy in Tropics for AOI Delhi State.
Dr C K Joshi elected President of Mumbai Branch.
Dr J.Narayana elected as President of Mysore Branch.
Dr P V Rajinder Kumar elected President of Madras Branch.
Dr Pacifica Simon obtained Phd from from Madras University
Rajasthan AOI startled Dr G. Narayanan Oration
AIIMS :Department of ENT AIIMS,Delhi conducted a Course on Skull Base Surgery.
Dr S.Kameswaran (Madras)delivered Guest Lecture on Otolarynglogy in Tropics for AOI Delhi State.
Dr C K Joshi elected President of Mumbai Branch.
Dr J.Narayana elected as President of Mysore Branch.
Dr P V Rajinder Kumar elected President of Madras Branch.
Dr Pacifica Simon obtained Phd from from Madras University
Rajasthan AOI startled Dr G. Narayanan Oration
AIIMS :Department of ENT AIIMS,Delhi conducted a Course on Skull Base Surgery.
ISOCON 2010
18th Annual Conference of Indian Society of Otology February 5 to 7 2010 at Coimbatore. Contact:- Dr NJ Rajan,Org.Secretary, ENT Clinic,Main Bazar,Ooty-643001. Email:-dr.njrajan@rediffmail.com, Mob:09443095756 | |
The American Academy of Otolaryngology- Annual Meeting & OTO EXPO at Boston, Massachusetts, USA on September 26-29, 2010.
October 30, 2009
The American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) is pleased to announce that its next Annual Meeting & OTO EXPO will take place in Boston, Massachusetts, USA. Please join us at the world’s largest gathering of the specialty, September 26-29, 2010.
Please post the following on your website or share it with your colleagues: The 2010 Call for Papers will be available at http://www.entnet.org/annual_meeting/, where abstracts may be submitted:
* Miniseminars and Instruction Courses: submission opens November 9, 2009; deadline December 7, 2009; notification March 2010.
* Scientific Program: submission opens February 8, 2010; deadline March 8, 2010; notification May 2010.
Academy members enjoy special rates for meeting registration.
* Click here to learn more about becoming a member of AAO-HNS
* Download an application form (PDF)
* Email memberservices@entnet.org with questions about AAO-HNS membership
Starting mid-May 2010, register online for the Annual Meeting & OTO EXPO. Look for the April Bulletin, which carries the preliminary program supplement.
Among special events for international registrants are a reception and orientation for first-time attendees, Saturday, September 25, and an International Dessert Reception open to all international attendees on Tuesday, September 28. International visitors are encouraged to wear their national dress or a flag lapel pin at the President’s Reception September 26 and at all evening receptions.
Travel to the United States
For attendees who need a U.S. visa, an invitation letter can be requested at no extra charge when registering online. The U.S. government recommends applying for a visa at least five months before arrival in the USA. To learn more, visit http://www.unitedstatesvisas.gov/.
If you have questions, contact international@entnet.org. The Academy looks forward to welcoming you to the 2010 Annual Meeting & OTO EXPO, the world’s largest gathering of otolaryngologist—head and neck surgeo
Catherine R. Lincoln, CAE, MA has left a new comment on your post "The American Academy of Otolaryngology- Annual Mee...":
COMMENTS
Thanks, Dr Kalra! Dr Nikhil J. Bhatt, the newly appointed chair of the AAO-HNS International Otolaryngology Committee, plans to attend the AOICON Mumbai, January, 2010.
On behalf of the President and Board of the AAO-HNS he will extend a cordial invitation to all Indian otolaryngologists to attend the Boston meeting and will be happy to answer questions.
Catherine R. Lincoln, CAE, MA, Senior Manager, International/Humanitarian, international@entnet.org
WHO:The allegation by some, that the H1N1 pandemic is a fake is both scientifically wrong and historically inaccurate
Dr Keiji Fukuda, Special Adviser to the Director-General on Pandemic Influenza, briefs the media on pandemic influenza activity and clarifies some misconceptions in the news.
summery :-
1.In the first place I want to emphasize the world is going through a real pandemic. The description of it as fake, is both wrong and is irresponsible.
2.The second point is that WHO has been balanced and truthful in the information it provided to the public. It has not underplayed and it has not overplayed the risks of the pandemic.
3.The third point is that WHO has reached out to all parties who could help to reduce harm from the pandemic but we did take very great care to make sure that the advice received was not unduly influenced by commercial or non-public health interests
Click here to read details
summery :-
1.In the first place I want to emphasize the world is going through a real pandemic. The description of it as fake, is both wrong and is irresponsible.
2.The second point is that WHO has been balanced and truthful in the information it provided to the public. It has not underplayed and it has not overplayed the risks of the pandemic.
3.The third point is that WHO has reached out to all parties who could help to reduce harm from the pandemic but we did take very great care to make sure that the advice received was not unduly influenced by commercial or non-public health interests
Click here to read details
Endoscopic imaging techniques in the diagnosis of laryngeal carcinoma and its precursor lesions
[Article in German]
Arens C, Malzahn K, Dias O, Andrea M, Glanz H.
Hals-Nasen-Ohrenklinik, Justus-Liebig-Universität, Giessen.
BACKGROUND: In order to improve preoperative diagnostic work-up in treatment of patients with laryngeal cancer and its precursor lesions additional endoscopical imaging techniques have been developed: 1. Autofluorescence endoscopy; 2. Contact endoscopy; 3. Endoscopic high-frequency ultrasound. These imaging techniques are used during microlaryngoscopy to get further information about tumor extension and differentiation. This paper describes the diagnostic potential of these imaging techniques in the evaluation of cancerous lesions of the larynx. MATERIAL AND METHODS: Patients in different stages of laryngeal dysplasia, carcinoma in situ and laryngeal cancer were examined by means of the previous mentioned imaging techniques during microlaryngoscopy (Autofluorescence endoscopy [n = 38], contact endoscopy [n = 323], endoscopic high-frequency ultrasound [n = 60]) and the results were compared to pathohistological findings. In autofluorescence endoscopy cancerous mucosa was illuminated using blue filtered light (380-460 nm) to obtain autofluorescence for optical demarcation of the lesion. Contact endoscopy was performed after staining of the laryngeal mucosa with methylene blue (1%). Two different endoscopes with 60 x and 150 x magnification were used. In both techniques a video image was achieved by using a xenon light source and a special video camera to register autofluorescence. The endoscopical high-frequency ultrasound examination was performed after flooding the larynx with 0.9% saline. Newly developed ultrasound catheters with frequencies between 10 to 20 MHz were inserted in the laryngeal lumen and moved in a standardized pattern during the examination. RESULTS: During the autofluorescence examination of the endolaryngeal mucosa precancerous and cancerous lesions showed a red to violet fluorescence outlined against the light green autofluorescence of the normal mucosa. Hyperplastic hyperkeratotic epithelium revealed a higher intensity of light green or even whitish autofluorescence compared to normal mucosa autofluorescence. After staining the vocal cords with methylene blue, it was possible to observe the cells, nuclei and cytoplasm of the laryngeal mucosa and their different grades of abnormality using the specially developed contact endoscopes. Endoscopic high-frequency ultrasound (10 to 20 MHz) was able to measure the vertical extension of laryngeal carcinomas bigger than 3 mm in size. The involvement of the thyroid cartilage or the anterior commissure could be visualized. Preoperatively, the critical T2 stage could be evaluated more precisely. In precancerous lesions and microinvasive cancer ultrasound added no additional Information to the microlaryngoscopical picture. CONCLUSION: Autofluorescence, contact endoscopy as well as endoscopic high-frequency ultrasound are promising new imaging techniques supplementing microlaryngoscopy: autofluorescence as well as contact endoscopy are suitable to differentiate dysplasia, carcinoma in situ, microinvasive lesions as well as the evaluation of tumorous margins, while high-frequency ultrasound improves the assessment of tumorous infiltration into the depth of the larynx. These imaging techniques enable the laryngologist to perform a more accurate diagnostic work-up in the assessment of laryngeal cancer and its precursor lesions.
PMID: 10666695 [PubMed - indexed for MEDLINE]
Note : Dr Arens delivered a talk in Kovalam today at Phonosurgery Conference
Arens C, Malzahn K, Dias O, Andrea M, Glanz H.
Hals-Nasen-Ohrenklinik, Justus-Liebig-Universität, Giessen.
BACKGROUND: In order to improve preoperative diagnostic work-up in treatment of patients with laryngeal cancer and its precursor lesions additional endoscopical imaging techniques have been developed: 1. Autofluorescence endoscopy; 2. Contact endoscopy; 3. Endoscopic high-frequency ultrasound. These imaging techniques are used during microlaryngoscopy to get further information about tumor extension and differentiation. This paper describes the diagnostic potential of these imaging techniques in the evaluation of cancerous lesions of the larynx. MATERIAL AND METHODS: Patients in different stages of laryngeal dysplasia, carcinoma in situ and laryngeal cancer were examined by means of the previous mentioned imaging techniques during microlaryngoscopy (Autofluorescence endoscopy [n = 38], contact endoscopy [n = 323], endoscopic high-frequency ultrasound [n = 60]) and the results were compared to pathohistological findings. In autofluorescence endoscopy cancerous mucosa was illuminated using blue filtered light (380-460 nm) to obtain autofluorescence for optical demarcation of the lesion. Contact endoscopy was performed after staining of the laryngeal mucosa with methylene blue (1%). Two different endoscopes with 60 x and 150 x magnification were used. In both techniques a video image was achieved by using a xenon light source and a special video camera to register autofluorescence. The endoscopical high-frequency ultrasound examination was performed after flooding the larynx with 0.9% saline. Newly developed ultrasound catheters with frequencies between 10 to 20 MHz were inserted in the laryngeal lumen and moved in a standardized pattern during the examination. RESULTS: During the autofluorescence examination of the endolaryngeal mucosa precancerous and cancerous lesions showed a red to violet fluorescence outlined against the light green autofluorescence of the normal mucosa. Hyperplastic hyperkeratotic epithelium revealed a higher intensity of light green or even whitish autofluorescence compared to normal mucosa autofluorescence. After staining the vocal cords with methylene blue, it was possible to observe the cells, nuclei and cytoplasm of the laryngeal mucosa and their different grades of abnormality using the specially developed contact endoscopes. Endoscopic high-frequency ultrasound (10 to 20 MHz) was able to measure the vertical extension of laryngeal carcinomas bigger than 3 mm in size. The involvement of the thyroid cartilage or the anterior commissure could be visualized. Preoperatively, the critical T2 stage could be evaluated more precisely. In precancerous lesions and microinvasive cancer ultrasound added no additional Information to the microlaryngoscopical picture. CONCLUSION: Autofluorescence, contact endoscopy as well as endoscopic high-frequency ultrasound are promising new imaging techniques supplementing microlaryngoscopy: autofluorescence as well as contact endoscopy are suitable to differentiate dysplasia, carcinoma in situ, microinvasive lesions as well as the evaluation of tumorous margins, while high-frequency ultrasound improves the assessment of tumorous infiltration into the depth of the larynx. These imaging techniques enable the laryngologist to perform a more accurate diagnostic work-up in the assessment of laryngeal cancer and its precursor lesions.
PMID: 10666695 [PubMed - indexed for MEDLINE]
Note : Dr Arens delivered a talk in Kovalam today at Phonosurgery Conference
Thursday, 14 January 2010
Ectopic Internal Carotid Artery presenting as oropharyngeal mass
Magnetic Resolution Angiography after gadolinium administration shows the helicoids-ectopic course of the right ICA, immediately after the carotid bulb. Notice also, the significant stenosis of the controlateral left ICA.
Cick here to read the original article
ENT on Internet
Power Point Presentation by Dr Ajit Man Singh ,
Consultant,MAX Hospital ,New Delhi
Click here to View Presentaion
Consultant,MAX Hospital ,New Delhi
Click here to View Presentaion
Wednesday, 13 January 2010
Treatment algorithm for patients with puberphonia
[Treatment algorithm for patients with puberphonia]
[Article in Turkish]
Kizilay A, Firat Y.
Department of Otolaryngology, Medicine Faculty of Inönü University, Malatya, Turkey.
OBJECTIVES: We evaluated the results of treatment for puberphonia and aimed to develop a treatment algorithm for patients with puberphonia. PATIENTS AND METHODS: Sixteen male patients (mean age 21.5 years; range 16 to 34 years) with puberphonia underwent voice therapy (3-10 sessions). Perceptual and acoustic analyses of vocal quality were performed in 12 patients. Perceptual analysis included the Voice Handicap Index (VHI) and videolaryngostroboscopy (VLS) and acoustic evaluations included F0 (fundamental frequency), jitter, shimmer, and NNE (normalized noise energy). RESULTS: Following voice therapy, all scores of the VHI showed significant improvements (p=0.001). There was a significant improvement in vibratory pattern and mucosal wave of vocal cords in VLS evaluation (p=0.004 and p=0.002, respectively). Among acoustic parameters, only the mean F0 showed a significant change from 246 Hz to 134 Hz after treatment (p=0.001). Stabilization of F0 could not be achieved in two patients, one of whom underwent type III thyroplasty. CONCLUSION: The main difficulties encountered in the treatment of puberphonia include stabilization of the attained F0 and widening the frequency range. Implementation of the treatment algorithm through a step-by-step approach provides an objective way of assessing the disease and its management.
PMID: 19293621 [PubMed - in process]
[Article in Turkish]
Kizilay A, Firat Y.
Department of Otolaryngology, Medicine Faculty of Inönü University, Malatya, Turkey.
OBJECTIVES: We evaluated the results of treatment for puberphonia and aimed to develop a treatment algorithm for patients with puberphonia. PATIENTS AND METHODS: Sixteen male patients (mean age 21.5 years; range 16 to 34 years) with puberphonia underwent voice therapy (3-10 sessions). Perceptual and acoustic analyses of vocal quality were performed in 12 patients. Perceptual analysis included the Voice Handicap Index (VHI) and videolaryngostroboscopy (VLS) and acoustic evaluations included F0 (fundamental frequency), jitter, shimmer, and NNE (normalized noise energy). RESULTS: Following voice therapy, all scores of the VHI showed significant improvements (p=0.001). There was a significant improvement in vibratory pattern and mucosal wave of vocal cords in VLS evaluation (p=0.004 and p=0.002, respectively). Among acoustic parameters, only the mean F0 showed a significant change from 246 Hz to 134 Hz after treatment (p=0.001). Stabilization of F0 could not be achieved in two patients, one of whom underwent type III thyroplasty. CONCLUSION: The main difficulties encountered in the treatment of puberphonia include stabilization of the attained F0 and widening the frequency range. Implementation of the treatment algorithm through a step-by-step approach provides an objective way of assessing the disease and its management.
PMID: 19293621 [PubMed - in process]
Tuesday, 12 January 2010
2ND INTERNATIONAL HEAD NECK ONCOLOGY CONFERENCE & WORKSHOP,JAN 29-31,2010,MUMBAI
The dept of E.N.T and head and neck surgery, is organizing the 2ND INTERNATIONAL HEAD NECK ONCOLOGY CONFERENCE & WORKSHOP on the 29th, 30th and 31st of January 2010 at the ITC CENTRAL SHERATON, Parel, Mumbai.
International stalwarts like Dr Ashok Shaha (MSKCC ,New York ) , Dr Wolfgang Steiner, (University of Goettingen / Germany), Dr Sandeep Samant (U.S.A) and Dr Anand Deveiah (U.S.A) have confirmed their participation. Leading national faculty from all parts of the country will be there
First two days will be dedicated to lectures, panel discussions and operative CDs on latest development in head neck surgery including endoscopic skull based surgery and laser surgery. There will be a hands-on cadaveric workshop on the third day.
International and national faculty will demonstrate surgical procedures and participants can operate on the cadavers. Limited seats are available. So its FIRST COME FIRST SERVE
Org Secretary
Dr Jyoti P Dabholkar
DEPT OF ENT & HEAD-NECK SURGERY, SETH G S MEDICAL COLLEGE & KEM HOSPITAL, PAREL, MUMBAI-12 INDIA
PHONE:+91 22 4136051 ext.ENT
FAX: +91 22 4143435
E MAIL: kemotohns@rediffmail.com
Latest ammendment of “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002
a) Gifts: A medical practitioner shall not receive any gift from any pharmaceutical or allied health care industry and their sales people or representatives
b) Travel facilities: A medical practitioner shall not accept any travel facility inside the country or outside, including rail, air, ship , cruise tickets, paid vacations etc. from any pharmaceutical or allied healthcare industry or their representatives for self and family members for vacation or for attending conferences, seminars, workshops, CME programme etc as a delegate
c) Hospitality: A medical practitioner shall not accept individually any hospitality like hotel accommodation for self and family members under any pretext.
d) Cash or monetary grants: A medical practitioner shall not receive any cash or monetary grants from any pharmaceutical and allied healthcare industry for individual purpose in individual capacity under any pretext. Funding for medical research, study etc. can only be received through approved institutions by modalities laid down by law / rules / guidelines adopted by such approved institutions, in a transparent manner. It shall always be fully disclosed.
e) Medical Research: A medical practitioner may carry out, participate in, work in research projects funded by pharmaceutical and allied healthcare industries. A medical practitioner is obliged to know that the fulfillment of the following items (i) to (vii) will be an imperative for undertaking any research assignment / project funded by industry – for being proper and ethical. Thus, in accepting such a position a medical practitioner shall:-
(i) Ensure that the particular research proposal(s) has the due permission from the competent concerned authorities.
(ii) Ensure that such a research project(s) has the clearance of national/ state / institutional ethics committees / bodies.
(iii) Ensure that it fulfils all the legal requirements prescribed for medical research.
(iv) Ensure that the source and amount of funding is publicly disclosed at the beginning itself.
(v) Ensure that proper care and facilities are provided to human volunteers, if they are necessary for the research project(s).
(vi) Ensure that undue animal experimentations are not done and when these are necessary they are done in a scientific and a humane way.
(vii) Ensure that while accepting such an assignment a medical practitioner shall have the freedom to publish the results of the research in the greater interest of the society by inserting such a clause in the MoU or any other document / agreement for any such assignment.
f) Maintaining Professional Autonomy: In dealing with pharmaceutical and allied healthcare industry a medical practitioner shall always ensure that there shall never be any compromise either with his / her own professional autonomy and / or with the autonomy and freedom of the medical institution.
g) Affiliation: A medical practitioner may work for pharmaceutical and allied healthcare industries in advisory capacities, as consultants, as researchers, as treating doctors or in any other professional capacity. In doing so, a medical practitioner shall always:
(i) Ensure that his professional integrity and freedom are maintained.
(ii) Ensure that patients interest are not compromised in any way.
(iii) Ensure that such affiliations are within the law.
(iv) Ensure that such affiliations / employments are fully transparent and disclosed.
h) Endorsement: A medical practitioner shall not endorse any drug or product of the industry publically. Any study conducted on the efficacy or otherwise of such products shall be presented to and / or through appropriate scientific bodies or published in appropriate scientific journals in a proper way”.
b) Travel facilities: A medical practitioner shall not accept any travel facility inside the country or outside, including rail, air, ship , cruise tickets, paid vacations etc. from any pharmaceutical or allied healthcare industry or their representatives for self and family members for vacation or for attending conferences, seminars, workshops, CME programme etc as a delegate
c) Hospitality: A medical practitioner shall not accept individually any hospitality like hotel accommodation for self and family members under any pretext.
d) Cash or monetary grants: A medical practitioner shall not receive any cash or monetary grants from any pharmaceutical and allied healthcare industry for individual purpose in individual capacity under any pretext. Funding for medical research, study etc. can only be received through approved institutions by modalities laid down by law / rules / guidelines adopted by such approved institutions, in a transparent manner. It shall always be fully disclosed.
e) Medical Research: A medical practitioner may carry out, participate in, work in research projects funded by pharmaceutical and allied healthcare industries. A medical practitioner is obliged to know that the fulfillment of the following items (i) to (vii) will be an imperative for undertaking any research assignment / project funded by industry – for being proper and ethical. Thus, in accepting such a position a medical practitioner shall:-
(i) Ensure that the particular research proposal(s) has the due permission from the competent concerned authorities.
(ii) Ensure that such a research project(s) has the clearance of national/ state / institutional ethics committees / bodies.
(iii) Ensure that it fulfils all the legal requirements prescribed for medical research.
(iv) Ensure that the source and amount of funding is publicly disclosed at the beginning itself.
(v) Ensure that proper care and facilities are provided to human volunteers, if they are necessary for the research project(s).
(vi) Ensure that undue animal experimentations are not done and when these are necessary they are done in a scientific and a humane way.
(vii) Ensure that while accepting such an assignment a medical practitioner shall have the freedom to publish the results of the research in the greater interest of the society by inserting such a clause in the MoU or any other document / agreement for any such assignment.
f) Maintaining Professional Autonomy: In dealing with pharmaceutical and allied healthcare industry a medical practitioner shall always ensure that there shall never be any compromise either with his / her own professional autonomy and / or with the autonomy and freedom of the medical institution.
g) Affiliation: A medical practitioner may work for pharmaceutical and allied healthcare industries in advisory capacities, as consultants, as researchers, as treating doctors or in any other professional capacity. In doing so, a medical practitioner shall always:
(i) Ensure that his professional integrity and freedom are maintained.
(ii) Ensure that patients interest are not compromised in any way.
(iii) Ensure that such affiliations are within the law.
(iv) Ensure that such affiliations / employments are fully transparent and disclosed.
h) Endorsement: A medical practitioner shall not endorse any drug or product of the industry publically. Any study conducted on the efficacy or otherwise of such products shall be presented to and / or through appropriate scientific bodies or published in appropriate scientific journals in a proper way”.
Dysmorphology in Otolaryngology
Dysmorphology is the study of disordered development resulting in recognizable morphologic abnormalities that fall outside the range of normal human variation. The late David Smith, MD, a superb dysmorphologist and the original author of the illustrated guide to syndromes entitled Recognizable Patterns of Human Malformation (WB Saunders, Philadelphia), coined the term dysmorphology. The goal of any dysmorphic assessment is to correctly interpret the pattern of structural anomalies and to arrive at the diagnosis.
The practicing specialist dealing with the ear, nose, and buccopharyngeal region is now confronted more frequently with problems related to congenital anomalies. The spectacular advances in basic and clinical genetics during the past 2 decades have brought congenital malformations and inherited disorders to the forefront of medical attention and care.
CLICK HERE TO READ MORE
The practicing specialist dealing with the ear, nose, and buccopharyngeal region is now confronted more frequently with problems related to congenital anomalies. The spectacular advances in basic and clinical genetics during the past 2 decades have brought congenital malformations and inherited disorders to the forefront of medical attention and care.
CLICK HERE TO READ MORE
Rhinotillexomania
J Clin Psychiatry. 2001 Jun;62(6):426-31.
A preliminary survey of rhinotillexomania in an adolescent sample.
Andrade C, Srihari BS.
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. andrade@nimhans.kar.nic.in
BACKGROUND: Rhinotillexomania is a recent term coined to describe compulsive nose picking. There is little world literature on nose-picking behavior in the general population. METHOD: We studied nose-picking behavior in a sample of 200 adolescents from 4 urban schools. RESULTS: Almost the entire sample admitted to nose picking, with a median frequency of 4 times per day; the frequency was > 20 times per day in 7.6% of the sample. Nearly 17% of subjects considered that they had a serious nose-picking problem. Other somatic habits such as nail biting, scratching in a specific spot, or pulling out of hair were also common; 3 or more such behaviors were simultaneously present in 14.2% of the sample, only in males. Occasional nose bleeds complicating nose picking occurred in 25% of subjects. Several interesting findings in specific categories of nose pickers were identified. CONCLUSION: Nose picking is common in adolescents. It is often associated with other habitual behaviors. Nose picking may merit closer epidemiologic and nosologic scrutiny.
PMID: 11465519 [PubMed - indexed for MEDLINE]
A preliminary survey of rhinotillexomania in an adolescent sample.
Andrade C, Srihari BS.
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. andrade@nimhans.kar.nic.in
BACKGROUND: Rhinotillexomania is a recent term coined to describe compulsive nose picking. There is little world literature on nose-picking behavior in the general population. METHOD: We studied nose-picking behavior in a sample of 200 adolescents from 4 urban schools. RESULTS: Almost the entire sample admitted to nose picking, with a median frequency of 4 times per day; the frequency was > 20 times per day in 7.6% of the sample. Nearly 17% of subjects considered that they had a serious nose-picking problem. Other somatic habits such as nail biting, scratching in a specific spot, or pulling out of hair were also common; 3 or more such behaviors were simultaneously present in 14.2% of the sample, only in males. Occasional nose bleeds complicating nose picking occurred in 25% of subjects. Several interesting findings in specific categories of nose pickers were identified. CONCLUSION: Nose picking is common in adolescents. It is often associated with other habitual behaviors. Nose picking may merit closer epidemiologic and nosologic scrutiny.
PMID: 11465519 [PubMed - indexed for MEDLINE]
Monday, 11 January 2010
Microsurgery of the Ear & Middle Ear Implants 7-8 February 2010,Gangaram Hospital ,Delhi
CLICK HERE TO VIEW BROCHURE
Dear Colleagues,
We invite you on behalf of the ENT Department at Sir Ganga Ram Hospital to come to Delhi and attend the 21st Annual Workshop on Microsurgery of the Ear & Middle Ear Implants. The 2 day course is from 7-8 february and by then the weather should be pleasant and we are keeping to our tradition of having an informal atmosphere where the participants are free to ask questions during the surgeries to clear their doubts. A minimum of 8-10 cases will be operated upon and the course will also include demonstration of a temporal bone dissection by Dr A K Lahiri. This will be of great help for the students of ear surgery in improving their concept of temporal bone anatomy.
Looking forward to seeing you here in Delhi,
Dr A K Lahiri Dr Shalabh Sharma
Course Directors.
10th Rhinoplasty and cosmetic Facial surgery workshop 2010,27-30October 2010,Bangkok
10th Rhinoplasty and cosmetic Facial surgery workshop 2010
Date: 2 7th to 30th October 2010
Venue- Hotel Grand Sukhmit, Bangkok, Thailand
Facial Plastic Center Indore is organizing a workshop on Rhinoplasty and Aesthetic Facial Surgery .There will be, lectures and video presentations on various Rhinoplasty Techniques, Hair Transplant, lasers in facial plastic surgery Botox Injection techniques, Face lift etc-
Course Director PROF. DR.B.BASER
Workshop Registration fee US$250 BEFORE 30TH March and$400 after that
Please see special Workshop Travel package for Indian delegates
CLICK HERE TO SEE DETAILS
For details contact
Organizing Secretaries
Dr.Divya Prabhat-divyaprabhat@gmail.com
Cell no.09820003680
Dr.Bachi Hathiram - bachi.hathiram@rediffmail.com
Cell no-09323699192
Date: 2 7th to 30th October 2010
Venue- Hotel Grand Sukhmit, Bangkok, Thailand
Facial Plastic Center Indore is organizing a workshop on Rhinoplasty and Aesthetic Facial Surgery .There will be, lectures and video presentations on various Rhinoplasty Techniques, Hair Transplant, lasers in facial plastic surgery Botox Injection techniques, Face lift etc-
Course Director PROF. DR.B.BASER
Workshop Registration fee US$250 BEFORE 30TH March and$400 after that
Please see special Workshop Travel package for Indian delegates
CLICK HERE TO SEE DETAILS
For details contact
Organizing Secretaries
Dr.Divya Prabhat-divyaprabhat@gmail.com
Cell no.09820003680
Dr.Bachi Hathiram - bachi.hathiram@rediffmail.com
Cell no-09323699192
Sunday, 10 January 2010
FESSCON,Guwahati ,January 29-31,2010
Lasers in ENT on 27 th january 2010,Gurgaon
You will be glad to know that Department of ENT & Head Neck surgery medanta medicity is organising Workshop on lasers in ENT on 27 th january 2010
I would be grateful if you could carry the information on your website . I am enclosing the brochure as attachment
click here to view brochure
Dr KK Handa
Head Deptt. of ENT & Head Neck Surgery
Medanta Medicity
Gurgaon
Mobile 09871189790
Post laryngectomy rehabilitation course,February 6-7,Mumbai(TATA Hospital)
Click here to Download Brochure
An international course on global post laryngectomy rehabilitation academy practical course with live hands on training at tata memorial hospital. -Mumbai -India
Course date 6-7 February 2010.
Venue – TATA memorial hospital - Mumbai ,India
Features ;
A complete kit of voice prosthesis with
rehab aid & accessories .cd.
All participants will be provided with the internation global post laryngectomy rehabilitation academy course certificate.
This course is an international course which is run by Netherlands cancer institute - Amsterdam.
Key feature is all the participants will have opportunity to learn hands on - with live patients prosthesis replacements.
2nd GPRA workshop is being held on 6th and 7th february at Tata memorial hospital (TMH), Mumbai.
Course registration fee is as follows:
Post-graduates and speech pathologists: Rs. 2500/-
Consultants: Rs 4500/-
Registration fee includes: 1) 2 days coffee/tea/ lunch
2) 1 cocktail dinner
3) a complete training kit of voice- prosthesis with rehab & accesories + CD of worth INR 12000/-
Registration fee with brochure is attached.
Kindly draw the cheque in favour of " TMH-GPR academy" payable at Mumbai.
Limited seats, 20 only; register early to avoid dissapointment.
Contact: 1) Dr Devendra Chaukar, (organizing secretary)
Tel- 022-24177238, Mob: 9820506232
Email: dchaukar@gmail.com
2) Dr Gurmeet Bacher, (organizing secretary)
Speech Pathologist -Head and Neck Unit- TMH, Mumbai.
Tel: 022 2417000 ext 4506
Email: gurmitlatika@rediffmail.com
Saturday, 9 January 2010
Rhinoplasty & Facial RejuvenationWorkshop,February 13-14,2010,Pune
click image to enlarge
Dear Friends,
You are all invited for 'Rhinoplasty & Facial RejuvenationWorkshop', in Pune in Feb 2010.
Brochure is attached with this mail.
For Reg. contact ;
Dr. Amol Deshpande
Hon.Org.Secretary,
9822404185
9922664114
rhinoplastypune@gmail.com
dramolent@gmail.com
Dear Friends,
You are all invited for 'Rhinoplasty & Facial RejuvenationWorkshop', in Pune in Feb 2010.
Brochure is attached with this mail.
For Reg. contact ;
Dr. Amol Deshpande
Hon.Org.Secretary,
9822404185
9922664114
rhinoplastypune@gmail.com
dramolent@gmail.com
First French India ENT Meeting ,March 21-28,2010
The French ENT Society is organizing the 1st French – Indian ENT meeting, to be held in Dehli, Agra and Jaïpur from March 21 to 28, 2010.
The purpose of this meeting is to allow French and Indian physicians to exchange their viewpoints and latest findings in the fields of audiology and otolaryngology.
We would like to invite you and your colleagues to participate in our conference in March.
There will be over 200 French ENT specialists traveling to India to participate at this meeting.
If you are interested, please contact me at contact@rfi-orl.com
Sincerely,
Pr Frédéric Chabolle
Secretary General of the French ENT Society
Monday, 4 January 2010
Saturday, 2 January 2010
DNB OSCE Mock Examination in Kolkata
DNB OSCE Mock Examination on 22nd and 23rd January' 2009 in Kolkata.
Faculty will include 5-7 DNB examiners from all over the country, course will include both OSCE and Long case, there will be facility for interacting with the examiners.
Interested members can contact me (sabgon@yahoo.com)
Dr Sabyasachi Gon
Faculty will include 5-7 DNB examiners from all over the country, course will include both OSCE and Long case, there will be facility for interacting with the examiners.
Interested members can contact me (sabgon@yahoo.com)
Dr Sabyasachi Gon
Delayed cerebrospinal fluid leak following septoplasty.
Ann Otol Rhinol Laryngol. 2009 Sep;118(9):636-8.
Delayed cerebrospinal fluid leak following septoplasty.
Thakar A, Lal P, Verma R.
Department of Otolaryngology-Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
We report on the clinical syndrome of delayed cerebrospinal fluid leak following septoplasty. We describe 2 such cases that we treated, and 1 other case described in the literature. A review of these 3 cases indicates a characteristic clinical and radiologic presentation and a consistent site of cerebrospinal fluid leak. All cases presented with cerebrospinal fluid leak 12 to 22 weeks after septoplasty and had slit-shaped dehiscences at the horizontal lamella of the cribriform plate. Endoscopic repair was successful in all. Delayed cerebrospinal fluid leaks may occur as a consequence of septal surgery.
It is probable that uncontrolled twisting and rocking manipulations of the perpendicular plate of the ethmoid bone are transmitted to, and injure, the cribriform plate.
PMID: 19810603 [PubMed - indexed for MEDLINE]
Delayed cerebrospinal fluid leak following septoplasty.
Thakar A, Lal P, Verma R.
Department of Otolaryngology-Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
We report on the clinical syndrome of delayed cerebrospinal fluid leak following septoplasty. We describe 2 such cases that we treated, and 1 other case described in the literature. A review of these 3 cases indicates a characteristic clinical and radiologic presentation and a consistent site of cerebrospinal fluid leak. All cases presented with cerebrospinal fluid leak 12 to 22 weeks after septoplasty and had slit-shaped dehiscences at the horizontal lamella of the cribriform plate. Endoscopic repair was successful in all. Delayed cerebrospinal fluid leaks may occur as a consequence of septal surgery.
It is probable that uncontrolled twisting and rocking manipulations of the perpendicular plate of the ethmoid bone are transmitted to, and injure, the cribriform plate.
PMID: 19810603 [PubMed - indexed for MEDLINE]
Subscribe to:
Posts (Atom)